Neurocern

How can insurance actuaries leverage artificial intelligence engines and neuroinformatics to predict cost of care and make smarter, more data-driven decisions? In this interview with and the of Actuaries, Neurocern founder and CEO, Dr. Anitha Rao shares how, by embracing advanced AI, companies can apply a neurologist’s expertise to structured claims data at scale to generate meaningful clinical insights for better financial and health outcomes. Watch now: https://bit.ly/3Os78Th

SOA Research Institute: Dementia, Neurology Deserts and Long-Term Care Report co-authors Robert Eaton, FSA, MAAA, Principal, Consulting Actuary, Milliman; and Anitha Rao, MD, MA, Neurocern, CEO and Founder, discuss their resear...

Neurocern’s AI scores big by identifying more than $20M in uncaptured revenue for small health plans and ACOs using advanced HCC risk suspecting analytics: Read more: https://bit.ly/3C9QbHj

At Neurocern, we use an “expert system” (a type of artificial intelligence) to connect fragmented health data and enrich it for actionable insights to improve health and financial outcomes — but what does that mean, really? Check out our latest blog post — written by Neurocern CTO Mark Wiendling — for a deep dive into different types of AI and how an expert system stacks up: bit.ly/3qVL2gR

In a new interview, our founder, Dr. Anitha Rao, shares how applying AI and analytics to insurance claims data can revolutionize clinical outcomes and reduce costs to insurers. Read more here: bit.ly/3zg7XaK

Meet Neurocern - Leading Neuroinformatics And Predictive Analytics Technology Company - Daily Company News Advances in technology and artificial intelligence, like Neurocern, use innovative analytical modeling that emulates the decision making of a...

We’re excited to announce that Neurocern's technology successfully demonstrated more than $370M in savings for Medicare and health insurance claims related to Alzheimer's disease drug eligibility. In a first-of-its-kind approach, Neurocern’s AI engine used predictive data modeling and advanced analytics to identify and triage patients to the right Alzheimer’s disease modifying therapy at the right time, thereby getting patients to treatments faster and saving insurers and the consumer millions in costs. Read the full press release: bwnews.pr/3Iws0pj

Anitha Rao Capco Diameter Health

Join us for grand rounds this week as our Founder, Dr. Anitha Rao, discusses how artificial intelligence and data analytics can be used to create patient cohorts, identify patients for high utilization, and flag patients most likely to meet drug eligibility at the individual and population level. Register here: https://www.eventbrite.com/e/leveraging-artificial-intelligence-data-to-improve-neurological-outcomes-registration-209511383187

Leveraging Artificial Intelligence & Data to Improve Neurological Outcomes University of Toledo College of Medicine, Department of Neurology Grand Rounds

Earlier this month, Neurocern CEO and founder, Dr. Anitha Rao, had the opportunity to speak at the 2021 Medicare Supplement Summit in Chicago. Today on the blog, Dr. Rao shares her top three takeaways from the conference and her thoughts on how medical data can be leveraged to predict — and reduce — cost of care: https://bit.ly/3lNqwwn

My Top Three Takeaways from the 2021 Medicare Supplement Conference in Chicago, Illinois – Neurocern Insights My Top Three Takeaways from the 2021 Medicare Supplement Conference in Chicago, Illinois ByAnitha Rao September 22, 2021September 22, 2021 This month, I had the opportunity to speak at the 2021 Medicare Supplement Summit in Chicago, Illinois. The panel discussed how medical data can be leve...

Data is king. How will Biogen’s Alzheimer’s drug impact the Medicare Supplement market? Neurocern’s AI-driven analytics can create actionable insights for Medigap underwriting, claims, and risk management. Join us at the 2021 Medicare Supplement Conference in Chicago on September 9 to hear from our founder, Dr. Anitha Rao, on how Neurocern’s predictive analytics detect cognitive impairment using Medicare supplement data. Read more on our blog: http://bit.ly/3Dy9uKG

When faced with a loved one who is experiencing new neurological symptoms, it can be overwhelming to know what types of specialists to see and what kinds of tests and assessments are needed. Today on the NeuroHealth Blog, Neurocern CEO and founder, Dr. Anitha Rao, explains two of the most common types of neurological assessments: a neurological workup and neuropsychological testing. Read more: https://bit.ly/3yz5ve9

Understanding Neurological and Neuropsychological Assessments – Neurocern Insights Understanding Neurological and Neuropsychological Assessments ByAnitha Rao August 10, 2021August 11, 2021 When faced with a loved one who is experiencing new neurological symptoms, caregivers and other family members often don’t know who to turn to for their neurological concerns. Differe...

As the leading neuroinformatics and predictive analytics technology company, Neurocern uses proprietary data mining and processing techniques to evaluate and process large datasets for new neurological insights. In our newest blog post, Neurocern founder, Dr. Anitha Rao, shares her insights into what neuroinformatics is and how it works to improve the lives of neurological and cognitive patients worldwide. Read more: https://bit.ly/3hmf6P6

Did you know one in three Medicare patients have had at least one office visit for a neurological condition? Access to neurological specialists is limited across much of the United States. Neurocern recently partnered with Milliman and the Society of Actuaries to explore the relationship between access to neurologists and the incidence of long-term care insurance cognitive claims. Read more on our blog at https://bit.ly/3vEEDa9 and use Neurocern to understand symptoms and find the right specialist based on your cognitive needs by starting a Neuro Health Intake at https://intake.neurocern.com.